PRDM16 and neoplasm: Seventy-five of 110 PTC patients presented a lower PRDM16 expression level in tumor tissue than that in the paired normal tissue, and only 31.82% patients had a higher PRDM16 expression level in tumor tissue compared with the paired normal tissue (Figure 1B).